Quanta CEO John Milad outlines the transitional stage where a company begins to seek large-scale funding for the first time, and debates market valuations.

In this roundup feature focusing on the developments in digital health, we highlight the key news and announcements from June.

UK-based Quanta will use the proceeds to ramp up European commercialization and bring its SC+ portable hemodialysis system to US-based acute and chronic care facilities, but ultimately hopes to enter the rising US home-based dialysis market.

The pandemic may accelerate a move toward versatile, single-solution renal replacement therapy in intensive care.